Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-09-08 00:00:00 ET · period of report 2025-09-04 · accession 0001415889-25-023878 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-09-08 | 2025-09-04+ | KNSA | Tessari Eben | COO | M - OptEx | $15.51 | +98.7K | 57.8K | New | +$1.53M |
| DM | 2025-09-08 | 2025-09-04+ | KNSA | Tessari Eben | COO | S - Sale+OE | $35.54 | -98.7K | 44.5K | -69% | -$3.51M |
| DM | 2025-09-08 | 2025-09-04+ | KNSA | Tessari Eben | COO | M - OptEx | $0.00 | -98.7K | 13.4K | -88% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-09-04 | M | A | 46,546 | $15.52 | 129,723 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-09-04 | M | A | 38,725 | $15.50 | 83,177 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2025-09-05 | S | D | 13,389 | $35.66 | 44,452 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $35.52 and $35.84. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 4 | Common | Class A Ordinary Share | 2025-09-04 | S | D | 85,271 | $35.52 | 44,452 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $35.50 and $35.545. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 5 | Common | Class A Ordinary Share | 2025-09-05 | M | A | 13,389 | $15.52 | 57,841 | D | — | — | |
| 6 | Derivative | Share Option | 2025-09-04 | M | D | 38,725 | $0.00 | 6,249 | D | $15.50 · — to 2030-09-09 | 38,725 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |
| 7 | Derivative | Share Option | 2025-09-05 | M | D | 13,389 | $0.00 | 0 | D | $15.52 · — to 2030-03-12 | 13,389 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |
| 8 | Derivative | Share Option | 2025-09-04 | M | D | 46,546 | $0.00 | 13,389 | D | $15.52 · — to 2030-03-12 | 46,546 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |